Clinical Trials Sponsored by Opsens Medical

Total 56406 results

Ipsen

Terminated

Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

Overactive Bladder

United Kingdom, Spain, Netherlands, Belgium, France, Germany, Czechia, Italy
Ipsen

Completed

Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome

Myofascial Pain Syndromes

Italy, Spain, Portugal, Czechia, Germany, Poland
Ipsen

Terminated

Quality of Life in Patients With Inoperable Malignant Bowel Obstruction (QoL in IMBO)

Intestinal Obstruction

Italy
Ipsen

Completed

Validation of Patient Reported Outcome Measures for Use in Vulvodynia

Vulvodynia

United States
Ipsen

Terminated

Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer (ANABRAQ)

Prostate Cancer

Spain
Ipsen

Completed

Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC

Renal Cell Carcinoma | Renal Cell Carcinoma Metastatic

Taiwan
Ipsen

Completed

Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.

Cervical Dystonia

United States
Ipsen

Completed

Description of Sign-and-symptom Associations at Acromegaly Diagnosis. (ACRO-POLIS)

Acromegaly

France
Ipsen

Withdrawn

Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG)

Acromegaly

Mexico
Ipsen

Completed

Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice (ULIS III)

Upper Limb Spasticity

Taiwan, United States, Germany, Australia, Hong Kong, Philippines, France, Russian Federation, Italy, Portugal, Brazil, Austria, Mexico, Poland
Ipsen

Completed

Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity of the Arm

Muscle Spasticity | Cerebrovascular Accident

Australia
Ipsen

Completed

A Study of the Combination of Electrical Stimulation and Dysport® in Myofascial Pain Syndrome.

Myofascial Pain Syndromes

Korea, Republic of
Ipsen

Completed

Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity

Muscle Spasticity | Cerebrovascular Accident

Hong Kong, Thailand, Malaysia, Philippines, Singapore
Ipsen

Completed

Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back Pain

Low Back Pain

Korea, Republic of
Ipsen

Completed

Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer (CHRONOS3)

Prostate Cancer

Romania
Ipsen

Completed

Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients (CALM-NET)

NeuroEndocrine Tumours

United Kingdom
Ipsen

Completed

Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET (SONNET)

Gastroenteropancreatic Neuroendocrine Tumors

Germany, Austria
Ipsen

Completed

Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly

Acromegaly

France, Germany, Spain, Belgium, Russian Federation, United Kingdom, Italy, Lithuania, Czechia, Romania, Poland, Netherlands
Ipsen

Terminated

Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly (DOPAACRO 002)

Acromegaly

Serbia, Belgium, Hungary, Ukraine
Ipsen

Completed

Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae

Digestive Fistulae

France, Russian Federation
Ipsen

Completed

Study to Evaluate a Dose of Telotristat Etiprate in Male and Female With Mild, Moderate and Severe Hepatic Insufficiency and Matched Healthy Subjects

Hepatic Impairment

Moldova, Republic of, Romania
Ipsen

Completed

A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints

Retention Disorders, Cognitive | Memory Disorders, Age-Related

France
Ipsen

Terminated

Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients

Huntington's Disease

Germany
Ipsen

Completed

BN83495 in Prostate Cancer (STX64PC)

Prostate Cancer

United States
Ipsen

Completed

Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study (DECAPUB)

Precocious Puberty

France
Ipsen

Completed

Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery (ESPORA)

Acromegaly

Spain
Ipsen

Completed

A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer (TRIPTOCARE LT)

Advanced Prostate Cancer

Netherlands, France, United Kingdom, Denmark, Latvia, Lithuania, Romania
Ipsen

Completed

Somatuline Predictive Factors in Acromegaly and NET (SOPRANo)

Acromegaly | Neuroendocrine Tumours

Switzerland, Austria, Germany
Ipsen

Terminated

Predictive Factors Study (TAPAS)

Acromegaly

Australia
Ipsen

Completed

Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm] (CDNISLongterm)

Cervical Dystonia

Austria, Germany
Ipsen

Completed

A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency

Growth Hormone Disorders

United Kingdom
Ipsen

Completed

One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma

Acromegaly

United Kingdom, France, Italy, Czechia, Germany, Turkey
Ipsen

Completed

A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke

Stroke, Acute | Neurological Impairment

Czechia, Poland, Romania, Russian Federation
Ipsen

Completed

Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke (P_Dysport_CS)

Upper Limb Spasticity Post-Stroke

Portugal
Ipsen

Terminated

Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer

Breast Cancer

Norway
Ipsen

Completed

Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer (PROS-PROSQoLI)

Prostate Cancer

Spain
Ipsen

Completed

Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Gastroenteropancreatic Neuroendocrine Tumor

United States
Ipsen

Completed

Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment. (ACRO QLQ)

Acromegaly

Poland
Ipsen

Completed

Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues (ANALUTS)

Prostate Cancer

Spain, Portugal
Ipsen

Terminated

A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours (PRELUDE)

Neuroendocrine Tumours

United Kingdom, France, Germany, Australia, Italy
Ipsen

Not yet recruiting

A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP) (FOPal)

Fibrodysplasia Ossificans Progressiva
Ipsen

Recruiting

A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development (EPITOME)

Spasticity as Sequela of Stroke

United States, Spain, France, Germany, Italy, Sweden, United Kingdom
Ipsen

Recruiting

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults (C-BEOND)

Chronic Migraine

United States, Canada, Czechia, Georgia, Germany, Italy, Poland, Spain, United Kingdom
Ipsen

Recruiting

Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC) (REPLICA)

Advanced or Metastatic Renal Cell Carcinoma

Belgium
Ipsen

Active, not recruiting

Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China

Acromegaly

China
Ipsen

Active, not recruiting

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. (LANTIMA)

Spasticity

United States, Spain, Austria, Bulgaria, Czechia, Germany, Hungary, Poland
Ipsen

Active, not recruiting

Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate (TriptoSwitch)

Prostate Cancer

Spain, Lithuania, Germany, France, Belgium, Netherlands, Czechia
Ipsen

Active, not recruiting

A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies. (PIVOINE)

Fibrodysplasia Ossificans Progressiva (FOP)

United States, France, Australia, Argentina, Italy, Canada, Sweden, United Kingdom, Brazil, Spain
Ipsen

Completed

Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

Renal Cell Carcinoma | Hepatocellular Carcinoma | Differentiated Thyroid Carcinoma

Korea, Republic of
Ipsen

Active, not recruiting

A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment (NAPOLI 3)

Metastatic Adenocarcinoma of the Pancreas

United States, Spain, Hungary, France, Portugal, Korea, Republic of, Germany, United Kingdom, Austria, Italy, Israel, Australia, Brazil, Czechia, Belgium, Russian Federation, Canada, Greece

3

Subscribe